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ABSTRACT
Background: Diarrhea affects a large proportion of children with
severe acute malnutrition (SAM). However, its etiology and clinical
consequences remain unclear.
Objective:We investigated diarrhea, enteropathogens, and systemic
and intestinal inflammation for their interrelation and their associ-
ations with mortality in children with SAM.
Design: Intestinal pathogens (n = 15), cytokines (n = 29), fecal calpro-
tectin, and the short-chain fatty acids (SCFAs) butyrate and propionate
were determined in children aged 6–59 mo (n = 79) hospitalized in
Malawi for complicated SAM. The relation between variables, diarrhea,
and death was assessed with partial least squares (PLS) path modeling.
Results: Fatal subjects (n = 14; 18%) were younger (mean 6 SD
age: 17 6 11 compared with 25 6 11 mo; P = 0.01) with higher
prevalence of diarrhea (46% compared with 18%, P = 0.03). Intestinal
pathogens Shigella (36%), Giardia (33%), and Campylobacter (30%)
predominated, but their presence was not associated with death or di-
arrhea. Calprotectin was significantly higher in children who died [me-
dian (IQR): 1360 mg/kg feces (2443–535 mg/kg feces) compared with
698 mg/kg feces (1438–244 mg/kg feces), P = 0.03]. Butyrate [median
(IQR): 31 ng/mL (112–22 ng/mL) compared with 2036 ng/mL (5800–
149 ng/mL), P = 0.02] and propionate [median (IQR): 167 ng/mL
(831–131 ng/mL) compared with 3174 ng/mL (5819–357 ng/mL),
P = 0.04] were lower in those who died. Mortality was directly related
to high systemic inflammation (path coefficient = 0.49), whereas di-
arrhea, high calprotectin, and low SCFA production related to death
indirectly via their more direct association with systemic inflammation.
Conclusions: Diarrhea, high intestinal inflammation, low concentra-
tions of fecal SCFAs, and high systemic inflammation are significantly
related to mortality in SAM. However, these relations were not medi-
ated by the presence of intestinal pathogens. These findings offer an
important understanding of inflammatory changes in SAM, which may
lead to improved therapies. This trial was registered at www.
controlled-trials.com as ISRCTN13916953. Am J Clin Nutr
2016;104:1441–9.
Keywords: cytokines, diarrhea, inflammation, inflammatory bowel
disease, severe acute malnutrition
INTRODUCTION
Severe acute malnutrition (SAM)12 in children results in un-
acceptably high mortality rates of #500,000 deaths/y world-
wide, although undernutrition underpins w45% of all deaths in
children under the age of 5 y (1). Despite standardized treatment
and refeeding protocols, inpatient mortality reaches up to 30%
in many hospitals (2–5). Current protocols rest on insufficient
high-quality evidence (6), thus a more thorough understanding
of the pathophysiology of malnutrition is required to improve
outcomes in this devastating condition.
Diarrhea accompanies SAM in 47–67% of cases and has been
associated with increased mortality (2, 3, 7). HIV enteropathy,
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environmental enteric dysfunction, acute infectious gastroenteritis,
and secondary osmotic diarrhea with subsequent dehydration are
diverse factors that likely contribute to the etiology of this diarrhea.
SAM is associated with structural and immunologic changes in the
small intestine, such as villous atrophy, increased permeability of
the intraepithelial layer, and local inflammation including infiltration
of lymphocytes (8, 9) and Th1-mediated upregulation of interferon g
(IFNg) (8). These changes that occur in SAM may share a common
pathophysiology with other T cell–mediated inflammatory condi-
tions of the small intestine, such as inflammatory bowel disease
(IBD) (10). Intestinal function and inflammation in SAM may be
modulated by short-chain fatty acids (SCFAs), which are fermen-
tation byproducts produced by the intestinal microflora and are an
important energy source for intestinal epithelial cells (11–14). Mal-
nutrition is also associated with altered systemic immune responses,
such as abnormal proinflammatory priming (15, 16) decreased
regulatory cytokines, and impaired immune activation (17–19).
The interplay between intestinal and systemic inflammation
and their relation to mortality in SAM is not well known. We
hypothesized that mortality in children with SAM is associated
with diarrhea and both higher intestinal and systemic inflammation,
which could be related to intestinal pathogens. In 79 children with
SAM, we evaluated the relation between: 1) diarrhea; 2) a panel of
intestinal pathogens (n = 15); 3) calprotectin as a marker of in-
testinal inflammation; 4) the SCFAs butyrate and propionate; 5)
markers of systemic inflammation (26 cytokines), and 6) mortality.
METHODS
Study design and patient recruitment
We studied 79 children who were drawn from a previous
randomized clinical trial originally designed to compare the
outcomes of 3 commonly used WHO rehabilitation diets (http://
www.isrctn.com/ISRCTN13916953). The 3 diets were isocaloric
but varied in their composition of carbohydrate and fat ratios.
Between January and July 2013, this study aimed to recruit 90
children aged 6–60 mo admitted to the malnutrition ward of
Queen Elizabeth Central Hospital in Blantyre, Malawi. These
children either failed a standardized appetite test with ready-to-
use therapeutic food or had complicated SAM. Complicated SAM
was defined as generalized edema including both feet, legs, hands,
and arms and face and/or midupper arm circumference,115 mm
or a weight-for-height or length ,–3 z score and medical compli-
cations or “danger signs” as defined in the current WHO guidelines
(6, 20). This includes respiratory distress, cyanosis, shock (delayed
capillary refill with fast and weak pulse plus temperature gradient),
impaired consciousness, hypoglycemia, convulsions, severe de-
hydration, profuse watery diarrhea, severe vomiting, and hypo-
thermia. Children were excluded from the original cohort if they
1) were HIV positive (or exposed, for children ,18 mo of age)
and had been readmitted to hospital for SAM within the past year,
2) had a packed cell volume of ,15%, 3) had severe hemody-
namic instability, 4) had unknown HIV status (because of testing
refusal by caregiver), or 5) had severe neurologic symptoms. From
this original cohort, we subsequently excluded children with con-
firmed or clinically suspected tuberculosis (n = 3), malaria (n = 7),
or insufficient serum for analyses (n = 1). HIV-positive or exposed
(for children ,18 mo of age) children diagnosed by rapid antibody
testing on admission were included in this study. All children
admitted received care according to the WHO guidelines
adapted to local Malawian use. This consisted of 1) the start
of a stabilization diet with WHO-standardized formula (named F-75
for 75 kcal/100 mL), 2) antibiotic therapy with chloramphenicol
and gentamicin, 3) anti-helminthic therapy with albendazole,
4) vitamin A and folic acid, and if no clinical improvement oc-
curred in 48 h, 5) the addition of the antibiotics metronidazole or
ciprofloxacin. Informed consent was obtained from the caregivers
before original patient enrollment. Ethical approval was obtained
from the College of Medicine Research Ethics Committee of the
University of Malawi, College of Medicine in Blantyre, Malawi,
and the Research Ethics Board of The Hospital for Sick Children
in Toronto, Canada. Primary outcomes were death and diarrhea.
Exposures included duration of stay, HIV reactivity, SAM phe-
notype marasmus compared with kwashiorkor, age, and anthro-
pometric measures. Potential confounders included undiagnosed
medical comorbidities, including nosocomial infections. The
detailed study flowchart is presented in Supplemental Figure 1.
Clinical data and biological sample collection
At admission, clinical, demographic and anthropometric data
were recorded including appetite, weight, presence and degree of
edema, and stool consistency and frequency. Death or discharge
from hospital was also documented. Diarrhea was reported by
maternal recall and defined as $3 loose or watery stools within
24 h. Stool and blood were obtained at admission. Stool was im-
mediately cooled and then frozen at 2808C. Blood was centri-
fuged 2180 3 g for 10 min at 48C and collected serum was stored
at 2808C until analyses.
Stool pathogens
Fecal intestinal pathogens (n = 15) were assessed by poly-
merase chain reaction at the Hospital for Sick Children, Toronto,
Canada, with the use of the Gastrointestinal Pathogen Panel
(Luminex Molecular Diagnostics) according to the manufacturer’s
instructions. In brief, nucleic acids were extracted from 100–150 mg
of formed or 100 mL of loose stool by easyMAG extractor
(bioMerieux) and underwent multiplexed polymerase chain re-
action for Salmonella spp., Shigella spp., Campylobacter jejuni/
coli, Yersinia enterocolitica (pathogenic serotype only), Escher-
ichia coli 0157:H7, non-0157 shiga-like toxin-producing E. coli,
Clostridium difficile toxin A/B, enterotoxigenic E. coli, Vibrio
cholerae, rotavirus A, adenovirus 40/41, norovirus GI/II, Giardia
lamblia, Entamoeba histolytica, and Cryptosporidium parvum.
Fecal calprotectin and SCFAs
Fecal calprotectin, a marker of intestinal inflammation, was mea-
sured by standard enzyme-linked immunoabsorbent assay by the
University Medical Center Groningen, Clinical Laboratory in the
Netherlands. The SCFA concentrations of propionate and butyrate
were analyzed by using gas chromatography–mass spectrometry
(GC-MS); freeze-dried samples were reconstituted in 75% ethanol,
homogenized, and centrifuged. Samples and standards [propionic
(C3:0) and butyric (C4:0) acids] were acidified then esterized with
pentafluorobenzyl bromide and di-isopropylamine before applica-
tion to GC-MS wells. The GC Agilent 7890A and the MSDAgilent
5975C quadrupole mass detector with carrier gas of helium heated
were used according to manufacturer’s protocol.








roningen user on 11 August 2020
Serum cytokines
Serum cytokine concentrations (n = 29) were determined by
using a human cytokine magnetic bead assay (EMD Millipore)
on the Luminex 200 platform with Xponent software (version
3.1; Luminex Corp.). Supplemental Table 1 lists all cytokines
assessed.
Statistical analysis
R statistical software (version 3.2.1) was used for all analysis
(21). As indicated, tables present either means6 SDs or medians
(IQRs). Age- and sex-corrected z scores for anthropometric
variables were calculated and are presented separately for children
with marasmus and kwashiorkor. Univariate analysis was done
with logistic regression or Fisher’s exact tests. Partial least
squares (PLS) methods were used to examine the relation between
diarrhea, calprotectin, SCFAs, selected markers of systemic in-
flammation (i.e., 9 cytokines), and death. Cytokine variables were
log-transformed, mean-centered, and scaled. Variables that did
not have enough variance to be analyzed (i.e., were undetected in
most samples) were automatically identified and filtered out
by using the nearZeroVar function implemented in the caret
package (22). By using plsdepot (23), the variance relating to
death or diarrhea was extracted and components assessed with
Q2 values. Q2 values are a performance measure calculated by
cross-validation that is based on the sum of squared errors. Q2
is equal to 1 minus the prediction error sum of squares divided
by the total sum of squares of the response variable. The higher
the value of Q2, the better the model is for prediction; negative
Q2 values indicate that the components of the model are not
predictive. Cytokines with correlation values of .0.30 to either
death or diarrhea were tested for stability by using sparse PLS
discriminant analysis as implemented in mixOmics (24). Fea-
ture stability was tested by using 10-fold cross-validation, i.e.,
the dataset was subdivided into 10 parts and the analysis se-
rially repeated by using 9 of the 10 data subsets. Variables that
were selected $90% of the time in the top 10 features asso-
ciated with either death or diarrhea were considered most ro-
bust and stable. The cytokines that showed 1) a P , 0.05 with
logistic regression, 2) a PLS discriminant analysis correlation
with either death or diarrhea of .0.3, and 3) a stability of
$90% were selected to be included in the PLS path modeling.
These cytokines in combination with diarrhea, calprotectin,
SCFAs, and death were used for PLS path modeling with plspm
(25). PLS path modeling is used to study a system of relation
between multiple “blocks” of variables (i.e., relation between
multiple data tables). Similar to principal component analysis, the
high dimensional blocks of variables can be reduced to a few
main components that can represent the node in the model, such
as systemic inflammation (see Supplemental Methods for more
information on the PLS path method). For this particular analysis,
62 patients were included because they had diarrhea status at ad-
mission and both blood and fecal samples. Variables were log-
transformed, mean-centered, and scaled, and missing fields were
imputed by using bag impute from the caret package (22). Diarrhea,
calprotectin, SCFAs, and systemic inflammation were then related
to mortality. Path coefficients were calculated for each inter-
connected node. These path coefficients indicate the strength and
direction of the relation between nodes and can be conceptually
interpreted as correlation coefficients.
RESULTS
Clinical characteristics, diarrhea, and mortality
In this cohort of 79 children with SAM, rates of diarrhea were
modest at admission, and mortality was substantial with an
overall rate of 23%. Differences in clinical characteristics of
children who died compared with those who recovered are de-
tailed in Table 1.
Patients who died were younger and tended to have lower
anthropometric measurements (i.e., body weight, weight-for-height
z score, and midupper arm circumference; this analysis was strati-
fied by edema status). Children who died were also more likely to
have marasmus than kwashiorkor. Diarrhea within the first 24 h of
admission was significantly associated with death. Although
prevalence of diarrhea after treatment initiation (72 h after admis-
sion) more than doubled, it was not a predictor of mortality in this
cohort. Parent-reported anorexia before admission did not differ
between children who recovered or died. Two-thirds of patients
were diagnosed with kwashiorkor, and one-third (35%) were HIV
reactive or exposed (for children,18 mo of age). HIV status was
not associated with death, and age, HIV status, and kwashiorkor
were not significantly associated with diarrhea (data not shown).
Enteric pathogens are highly prevalent, and intestinal
markers of inflammation are altered in children with
malnutrition
The presence of stool pathogens in relation to death is detailed
in Table 2. Most malnourished children harbored known intestinal
pathogens; of these, 44% had$2 pathogens. The bacteria Shigella
spp., C. jejuni/coli, and the parasite G. lamblia occurred most
often. Despite their high frequency and diversity, their presence
was not significantly associated with systemic inflammation (data
not shown) or with clinical outcomes of death (Table 2) or diarrhea
(Supplemental Table 2).
Based on an age-specific cutoff (26), fecal calprotectin con-
centrations were clinically elevated in the majority of patients
(76%,.214 mg/kg feces) and 49% had values.800 mg/kg feces.
Elevation of this intestinal inflammation marker was signifi-
cantly associated with death [median (IQR): 1360 mg/kg feces
(2443–535 mg/kg feces) compared with 698 mg/kg feces (1438–
244 mg/kg feces), P = 0.03)] (Figure 1A and Supplemental
Table 3). Calprotectin did not differ significantly between those
with and without diarrhea (Supplemental Table 4); however,
concentrations .800 mg/kg feces were associated with the pres-
ence of multiple intestinal pathogens (59% compared with 28%,
P = 0.02).
Low amounts of fecal butyrate and propionate were significantly
associated with death (Figure 1B and C and Supplemental Table 3),
and these SCFAs were similarly decreased and highly correlated (r =
0.77, df = 34, P, 0.001). Diarrhea also tended to be associated with
a decrease in SCFAs, but this was not significant when individually
testing butyrate and propionate in univariate analysis (Supplemental
Table 4). Also, they did not correlate with calprotectin or length of
reported anorexia before admission (data not shown).
Systemic inflammation is increased with SAM and is
related to death and diarrhea
Several markers of systemic inflammation positively correlated
with both diarrhea and death. Specific serum cytokines were found
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to be higher in children who died and also in children presenting
diarrhea at admission (Table 3 and Supplemental Tables 5 and 6).
The first PLS component that captures the main variability of
the cytokines with diarrhea was more modest with an R2 of 0.24,
Q2 of 0.08, and prediction error rate of 0.25, whereas death had
with its first component an R2 of 0.36, Q2 of 0.18, and cross-
validation prediction error rate of 0.19. Most cytokines showed
similar positive correlations patterns for both death and diar-
rhea, but their stability on cross-validation varied (Table 3).
Seven cytokines were found to robustly correlate with death:
granulocyte-colony stimulating factor (GCSF), IL13, IL1RA,
IL2, IL6, TNF-a, and TNF-b (Table 3 and Figure 2). Of these,
5 also robustly correlate with diarrhea (GCSF, IL2, IL6, TNF-a,
and TNF-b). These results were largely unchanged after cor-
recting for sex and age (data not shown). Cytokines were not
significantly predictive of pathogens, fecal calprotectin, or HIV
reactivity and exposure as assessed by low R2 and Q2 values
(data not shown).
TABLE 1
Comparison of clinical characteristics at admission in children with severe acute malnutrition1
All (n = 79) Recovery (n = 65) Death (n = 14) P2
Age, mo 23.3 6 11.7 24.7 6 11.4 17.0 6 11.2 0.01
Female 44/78 (56) 34/64 (53) 10/14 (71) 0.3
HIV reactive 28/79 (35) 21/65 (32) 7/14 (50) 0.2
Kwashiorkor 52/79 (66) 47/65 (72) 5/14 (36) 0.01
Weight at admission, kg
Marasmus (n = 27) 5.1 6 1.0 5.5 6 0.9 4.4 6 0.9 0.02
Kwashiorkor (n = 52) 8.2 6 2.1 8.8 6 1.9 7.1 6 2.6 0.07
MUAC3 at admission, cm
Marasmus (n = 27) 9.7 6 1.0 10.0 6 1.0 9.2 6 0.9 0.07
Kwashiorkor (n = 52) 12.5 6 1.6 12.6 6 1.0 11.3 6 2.4 0.09
Weight-for-height z score
Marasmus (n = 27) 24.9 6 1.0 24.7 6 0.8 25.4 6 1.2 0.08
Kwashiorkor (n = 51) 22.0 6 1.5 22.0 6 1.4 22.6 6 1.6 0.3
Diarrhea on day of admission 17/73 (23) 11/60 (18) 6/13 (46) 0.03
Diarrhea within 72 h of admission 46/79 (58) 37/65 (57) 9/14 (64) 0.6
Anorexia 5.1 6 6.3 4.86 6 6.3 6.17 6 6.3 0.5
Length of hospital stay, d 10.4 6 4.1 9.6 6 6.9 0.5
1Values are means 6 SDs or n/N (%). P values were obtained with logistic regression.
2 Significant at P , 0.05.
3MUAC, midupper arm circumference.
TABLE 2
Stool pathogens in children admitted with severe acute malnutrition who recovered or died1
All (n = 64) Recovery (n = 53) Death (n = 11) P FDR-P2
All pathogens
$1 pathogen 54 (84) 46 (87) 8 (73) 0.4 1
1 pathogen 26 (41) 23 (43) 3 (27) 0.5 1
2 pathogens 14 (22) 11 (21) 3 (27) 0.7 1
$3 pathogens 14 (22) 12 (23) 2 (18) 1 1
Bacteria
$1 bacteria 40 (63) 34 (64) 6 (55) 0.7 1
Shigella spp. 23 (36) 20 (38) 3 (27) 0.7 1
Campylobacter spp. 19 (30) 16 (30) 3 (27) 1 1
Enterotoxigenic Escherichia coli 10 (16) 9 (17) 1 (9) 1 1
Salmonella spp. 5 (8) 4 (8) 1 (9) 1 1
Shiga-like toxin-producing E. coli 1 (2) 1 (2) 0 (0) 1 1
Clostridium difficile 1 (2) 0 (0) 1 (9) 0.2 1
Parasites
$1 parasite 23 (36) 20 (38) 3 (27) 0.7 1
Giardia lamblia 21 (33) 20 (38) 1 (9) 0.08 0.8
Cryptosporidium parvum 2 (3) 0 (0) 2 (18) 0.03 0.6
Entamoeba histolytica 1 (2) 1 (2) 0 (0) 1 1
Viruses
$1 virus 17 (27) 14 (26) 3 (27) 1 1
Norovirus 8 (13) 7 (13) 1 (9) 1 1
Rotavirus 5 (8) 3 (6) 2 (18) 0.2 1
Adenovirus 4 (6) 4 (8) 0 (0) 1 1
1Values are n (%). P values were obtained with Fisher’s exact test. Yersinia enterocolitica, Escherichia coli 0157:H7,
and Vibrio cholerae were undetected.
2 FDR-P, Benjamini & Hochberg, i.e., false discovery rate adjusted P values.
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Diarrhea, calprotectin, SCFAs, systemic inflammation and
death are interrelated
PLS path modeling was used to indicate the strength and
direction of the relation between 5 nodes: 1) diarrhea, 2) calprotectin,
3) SCFAs, 4) markers of systemic inflammation (i.e., the 9 serum
cytokines that most robustly associated with either death or diarrhea;
5 were common to both, 2 were unique to death, and 2 were unique
to diarrhea), and 5) death (Tables 4 and 5 and Figure 3). Table 4
indicates the cross-correlation estimates between each variable and
their attributed nodes as well as with all other model nodes. The
SCFA node positively correlates with both butyrate and propionate,
which indicates that patients with a high SCFA index have high
values for these markers. Patients with high index values of sys-
temic inflammation have high cytokine concentrations in their se-
rum. Table 5 indicates the strength and directions of the calculated
relation between model nodes, and these are graphically represented
in Figure 3. Patients with diarrhea tended to have lower fecal cal-
protectin concentrations and lower SCFA concentrations but higher
systemic inflammation. Patients with higher concentrations of cal-
protectin had a higher index of systemic inflammation, whereas
higher SCFA concentrations were associated with reduced systemic
inflammation. High concentrations of SCFA tended to be directly
FIGURE 1 Concentrations of calprotectin (n = 68; A), propionate (n = 61; B), and butyrate (n = 61; C) in fecal samples from children with severe acute
malnutrition who recovered or died. Boxplots summarize the median (midline) and IQRs (upper and lower boxes); overlaid dots indicate all individual data points.
Medians (IQRs) for groups that recovered or died were as follows: for calprotectin, 697.5 mg/kg feces (1437.5–243.8 mg/kg feces) compared with 1360 mg/kg feces
(2442.5–535 mg/kg feces, P = 0.03); for propionate, 3173.8 ng/mL (5819.2–357.2 ng/mL) compared with 167.2 ng/mL (831.4–130.9 ng/mL, P = 0.04); and for butyrate,
2035.7 ng/mL (5799.6–149.1 ng/mL) compared with 31.3 ng/mL (112.3–21.6 ng/mL), P = 0.02). Group differences were tested by logistic regression. *P , 0.05.
FIGURE 2 Serum cytokine concentrations in children (n = 68) with severe acute malnutrition who recovered (n = 54) or died (n = 14). Cytokines
presented (n = 7) are those associated with death as obtained through partial least square–based feature selection. Boxplots summarize the medians and IQRs
of natural logarithms of cytokine concentrations. Overlaid dots present all individual data points. GCSF, granulocyte-colony stimulating factor.
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associated with less mortality, but SCFAs also showed an associa-
tion with reduced systemic inflammation. This indirect relation may
explain the link between SCFAs and mortality. Also, our model did
not directly associate diarrhea or calprotectin with death but sug-
gests that these markers may be linked to mortality indirectly
through their association with systemic inflammation. Pathogens
were not included in the final model because they did not im-
prove the overall fit, were not found to be associated with any
nodes, and caused instability on cross-validation.
DISCUSSION
Our study provides novel insight into themechanisms underlying
SAM-related deaths. Mortality is associated with diarrhea, low
concentrations of SCFAs, and heightened intestinal and systemic
inflammation.
Several studies have reported increased mortality rates in chil-
dren who have both SAM and diarrhea (2, 3). Our study supports
these findings, although our cohort had lower rates of diarrhea
(23%) than reported frequencies of 49% (3) and 67% (2). This
lower prevalence of diarrhea at admission may be due to mater-
nal recall bias or true differences. The increased diarrhea after
treatment initiation could reflect diet-induced osmotic changes.
More than 44% of children in our study harbored multiple
intestinal pathogens, which may indicate colonization or active
infection. Ferdous et al. (27) reported the prevalence of rotavirus at
30% and of Shigella at 18% in 316 rural Bangladeshi children with
moderate-to-severe malnutrition and diarrhea. Amadi et al. (28)
studied 194 children aged 6–24 mo n Zambia and reported the
prevalence of Cryptosporidium at 24%, and Salmonella at 18%,
Giardia at 6%, with a low prevalence of Shigella at 2%. We found
a predominance of Shigella, Giardia, and Campylobacter but a low
detection of enterotoxigenic E. coli, Salmonella, and Cryptospo-
ridium, and a very low prevalence of norovirus and adenovirus.
Collectively, these results indicate significant variability in
pathogen prevalence among children with SAM that may relate
TABLE 3














1 EGF 0.314 — 0.15 —
2 Eotaxin 0.14 — 20.03 —
3 GCSF 0.644 100 0.684 90
4 GMCSF 0.534 — 0.414 —
5 IFNa2 0.594 100 0.484 70
6 IFNg 0.394 — 0.17 —
7 IL10 0.26 — 0.29 —
8 IL12p40 0.26 — 0.11 —
9 IL12p70 0.644 100 0.554 80
10 IL13 0.354 — 0.54 100
11 IL15 0.594 — 0.584 70
12 IL17A 0.08 — 0.19 —
13 IL1RA 0.654 50 0.754 100
14 IL1a 0.16 — 0.12 —
15 IL2 0.744 100 0.744 100
16 IL5 0.24 — 0.17 —
17 IL6 0.564 100 0.614 100
18 IL7 0.26 — 0.364 —
19 IL8 0.34 — 0.44 —
20 IP10 0.28 — 0.14 —
21 MCP1 0.344 — 0.334 —
22 MIP1a 0.21 — 0.02 —
23 MIP1b 0.07 — 0.03 —
24 TNF-a 0.374 100 0.334 100
25 TNF-b 0.564 100 0.554 100
26 VEGF 0.24 — 0.23 —
1 IL3, IL4, and IL1b were not analyzed because they were undetected in most samples. EGF, epidermal growth factor;
GCSF, granulocyte-colony stimulating factor; GMCSF, granulocyte-macrophage colony stimulating factor; IFN, interferon;
IP, induced protein; MCP, monocyte chemoattractant protein; MIP, macrophage inflammatory protein; PLS, partial least
square; VEGF, vascular endothelial growth factor.
2 Cor indicates the correlation strength between the PLS-component 1 and either diarrhea or death. R2 indicates the
variance explained by component 1. Q2 indicates the predictive quality of component 1; Q2 is equal to 1 minus the
prediction error sum of squares divided by the total sum of squares of the response variable; negative Q2 values indicate
that the component is not predictive.
3 Feature stability indicates the percentage of times that a cytokine was selected as a top-10 feature by using sparse
PLS with 10-fold cross-validation.
4 Correlation .0.3 with component 1.
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to regional differences, patient selection, sampling protocols, and
analyses methods. Our study did not find associations between the
presence of pathogens and diarrhea as described by Opintan et al. (7).
However, our sample sizewas limited, and wewere unable to analyze
patterns of co-occurrence between pathogens. Semiquantitative anal-
yses of stool pathogens could be useful in future studies to better
differentiate between pathogens that have colonized the intestine
and those actively causing overt disease in children with SAM.
Fecal calprotectin was elevated in most of our patients with
ranges up to 5270 mg/kg feces. This suggests that children with
SAM have high degrees of intestinal inflammation, which is
consistent with a previous report (29). Interestingly, Hestvik et al.
(30) described heightened concentrations of fecal calprotectin in
healthy Ugandan infants with a median of 249 mg/kg feces, yet
they did not find differences linked to pathogens in stool. We also
did not find a clear relation between specific intestinal pathogens
and fecal calprotectin; however, children with multiple pathogens
did show higher concentrations. A higher calprotectin concen-
tration was also found in children who died than in those who
recovered. However, our PLS path model suggests that this link to
mortality may be indirect through an association with systemic
inflammation. Diarrhea tended to be associated with lower fecal
calprotectin concentrations and the SCFAs butyrate and pro-
pionate, but this relation was not conclusive. With increased
frequency of bowel movements, fecal markers may appear de-
creased because of frequent clearing of intestinal content; this
may explain the high variability of fecal calprotectin and the lack
of association with diarrhea or specific pathogens.
Interestingly, low concentrations of fecal butyrate and pro-
pionate were also associated with death. These byproducts of
bacterial fermentation provide energy to enterocytes and mod-
ulate metabolism (12). Furthermore, SCFAs are important reg-
ulators of intestinal immunity with anti-inflammatory properties
(14, 31). Also, butyrate is known to induce the cathelicidin LL-37
TABLE 5
Relation between diarrhea, calprotectin, SCFA, systemic inflammation, and death as obtained from PLS path modeling1
Cross-validation
Relation between nodes Direct Indirect Total Bootstrap mean SE P2
Diarrhea / calprotectin 20.222 0.000 20.222 20.161 0.207 0.08
Diarrhea / SCFAs 20.298 0.000 20.298 20.254 0.117 0.02
Diarrhea / systemic inflammation 0.345 0.008 0.354 0.381 0.119 0.005
Calprotectin / systemic inflammation 0.324 0.000 0.324 0.308 0.116 0.006
SCFAs / systemic inflammation 20.268 0.000 20.268 20.278 0.092 0.02
SCFAs / death 20.213 20.130 20.343 20.351 0.106 0.06
Systemic inflammation / death 0.485 0.000 0.485 0.497 0.099 ,0.001
1 Relation estimates between diarrhea, calprotectin, the composite measures of SCFAs, and markers of systemic inflammation
in relation to death. Direct and indirect relations are calculated between nodes, and total effects are the sum of these effects. SEs
and bootstrap means, i.e., the mean value of the calculated total relation estimates obtained from each round of bootstrapping, were
obtained through cross-validation. P indicates the significance of path coefficients between model nodes, which are graphically
represented with arrows in Figure 3. PLS, partial least squares; SCFA, short-chain fatty acid.
2P , 0.05 was considered statistically significant.
TABLE 4
Cross-correlation between each variable and 5 main nodes of the PLS path modeling analysis1
Diarrhea Calprotectin SCFA Systemic inflammation Death
Diarrhea 1 20.22 20.30 0.35 0.34
Calprotectin 20.22 1 0.03 0.24 0.17
SCFA
Propionate 20.28 0.04 0.97 20.32 20.35
Butyrate 20.30 0.02 0.98 20.38 20.40
Systemic inflammation
GCSF 0.25 0.24 20.25 0.71 0.33
IL1RA 0.11 0.25 20.42 0.76 0.45
IL6 0.23 0.17 20.20 0.64 0.33
IL2 0.19 0.09 20.24 0.72 0.45
TNF-a 0.30 0.13 20.12 0.38 0.29
TNF-b 0.23 0.13 20.16 0.61 0.32
IL13 0.02 0.05 20.20 0.45 0.37
IFNa2 0.43 20.04 20.16 0.59 0.33
IL12p70 0.22 0.22 20.20 0.63 0.25
Death 0.34 0.17 20.39 0.56 1
1 Cross-correlation estimates between diarrhea, calprotectin, SCFAs, markers of systemic inflammation, and death.
SCFA is a composite variable of both propionate and butyrate; systemic inflammation is composed of the most robust
cytokines associated with either death or diarrhea as obtained through feature selection (n = 9). Cross-correlation values are
between 0 and 1 and indicate the correlation between each variable and model nodes (i.e. diarrhea, calprotectin, SCFAs,
systemic inflammation, and death). GCSF, granulocyte-colony stimulating factor; IFN, interferon; PLS, partial least
squares; SCFA, short-chain fatty acid.
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(32), which are antimicrobial peptides that have broad-spectrum
activity against bacteria, viruses, and fungi. Patients with other
intestinal diseases, such as IBD, also have reduced fecal SCFA
concentrations, and this has been correlated to changes in the
enteric microbiome (33). SAM patients also show significant
microbiome changes that may affect SCFA production (34).
Apart from microbiome-related changes, ongoing anorexia in
children with SAM could have deprived the colonic microbiome
of fermentable nutrients leading to lower fecal SCFA concentra-
tions. However, the length of reported anorexia before admission
did not differ between children that died or recovered and also did
not correlate significantly with concentrations of SCFAs. Alter-
natively, starved colonic cells may uptake all available SCFAs to
meet energy requirements. However, high intestinal inflammation
has been associated with decreased SCFA uptake (35).
Replenishing SCFAs directly with, for example, phenyl butyrate
(32, 36) or indirectly by bacterial supplementation could help
reduce inflammation, increase antimicrobial peptides, and restore
normal intestinal barrier function and homeostasis. To date,
children with SAM have not clearly benefitted from probiotics
(37), but methods for delivery and maintenance of beneficial
microbiome communities may not have been fully explored.
Markers of systemic inflammation were higher in patients with
SAM and associated with death and diarrhea. Malnutrition is
a common cause of secondary immune deficiency, and previous
studies characterizing cytokine changes showed reductions in IL2
(17, 18, 38) and IFNg (18, 19) with inconsistent reductions in IL1
(38–40) and increases in IL10 (15, 17, 38) and TNF-a (17, 39).
Compared with reference ranges (33, 41–44), .50% of patients in
our cohort had higher cytokine concentrations for GCSF, IL10,
IL12p40, macrophage inflammatory protein 1a, and TNF-a. The
mechanisms underlying these cytokine shifts are unclear and may
be related to infections, ongoing response to cell damage induced
by lack of nutrients, and/or the loss of intestinal barrier function,
which allows antigens to seep into the bloodstream (45). Younger
age is associated with increased mortality, and younger children are
known to mount differential immune responses to pathogens
compared with older children (46). However, age-correction largely
unchanged the cytokine patterns associated with death. Finally,
SAM-associated systemic inflammation may parallel the proin-
flammatory shifts in cytokines that are seen in IBD with higher
TNF-a, IL1, IL6, IL12, and IFNg with decreased IL10 and TGF-b
(47) concentrations. These similarities should be interpreted with
caution but do warrant further investigation. Several authors have
paralleled the symptoms of SAM and IBD, and this has led to the
experimental use of established IBD treatments such as the anti-
inflammatory agent mesalazine in patients with SAM (29, 48).
Our study was limited by a relatively small sample size and
was not designed to fully investigate interactions or other cofactors
of mortality such as HIV, phenotype of SAM, dehydration,
electrolyte and metabolic disturbances, or inadequate antibiotic
absorption. Having an age-matched control groupwould have been
valuable, but recruitment proved infeasible because caregivers of
healthy children were decidedly opposed to venipuncture. For PLS
path modeling, preselecting the most robust cytokines related to
death or diarrhea was done to stabilize the cross validation; this
may not be a necessary with larger data sets. Better understanding
of the relation between malnutrition, systemic inflammation, local
inflammatory and functional changes in the intestine, and their
associations with diarrhea and mortality may lead to more targeted
treatments and a reduction of child mortality worldwide.
With quality research aimed at elucidating the pathophysiol-
ogy of intestinal changes in SAM, new targets for interventions
will be uncovered. More multicenter controlled clinical trials as
well as basic mechanistic and translational research are urgently
needed to provide a physiologic basis for the protocols currently
used to treat SAM. Further investigating the consequences of
sustained local and systemic inflammation and the links between
SCFA and mortality may lead to improved clinical risk assess-
ment and novel therapies targeting intestinal and nutritional
rehabilitation in these vulnerable children.
The authors thank Hilda Khengere, Alice Tsokonombwe, Agatha Gaussi,
Patricia Banda, and Agnes Malamula for their excellent clinical research support.
The authors’ responsibilities were as follows—PFvR and RHJB: designed
the research; WV and SJvV: conducted the research in Blantyre; CJV and
SJvV: provided the database; VDG, LZ, and SR: provided the laboratory
analyses; SA, CJV, CB, and PFvR: performed the statistical analysis; SA,
CJV, CB, JAB, and RHJB: wrote and provided the main editing of the
manuscript; MGN, JAB, and PFvR: provided expert opinion in immunology
and interpretation of data; RHJB: had primary responsibility for the final
content; and all authors: read and approved the manuscript. None of the
authors had a conflict of interest to disclose.
REFERENCES
1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M,
Ezzati M, Grantham-McGregor S, Katz J, Martorell R, et al. Maternal
and child undernutrition and overweight in low-income and middle-
income countries. Lancet 2013;382:427–51.
2. Irena AH, Mwambazi M, Mulenga V. Diarrhea is a major killer of
children with severe acute malnutrition admitted to inpatient set-up in
Lusaka, Zambia. Nutr J 2011;10:110.
3. Talbert A, Thuo N, Karisa J, Chesaro C, Ohuma E, Ignas J, Berkley JA,
Toromo C, Atkinson S, Maitland K. Diarrhoea complicating severe
acute malnutrition in Kenyan children: a prospective descriptive study
of risk factors and outcome. PLoS One 2012;7:e38321.
4. Maitland K, Berkley JA, Shebbe M, Peshu N, English M, Newton
CRJC. Children with severe malnutrition: can those at highest risk of
death be identified with the WHO protocol? PLoS Med 2006;3:e500.
FIGURE 3 Relation between diarrhea, calprotectin, SCFAs, systemic
inflammation, and death as estimated by partial least squares path modeling.
Children with diarrhea status and both blood and fecal samples (n = 62) were
included in this analysis. The path coefficients above each interconnecting
arrow indicate the strength and direction of the relation between the nodes of
the model. Diarrhea and calprotectin were not directly associated with death
but may be linked to mortality through systemic inflammation. Similarly,
SCFA shows an indirect association but may also partially contribute to
death directly. Pathogens were not included in this model as this did not
improve the overall fit (goodness of fit = 0.31), were not found to be asso-
ciated with any nodes, and caused instability on cross-validation. Solid lines
indicate a direct relation with P , 0.05; dashed lines indicate trends with
P , 0.1. SCFA, short-chain fatty acid.








roningen user on 11 August 2020
5. Heikens GT, Bunn J, Amadi B, Manary M, Chhagan M, Berkley JA,
Rollins N, Kelly P, Adamczick C, Maitland K, et al. Case management
of HIV-infected severely malnourished children: challenges in the area
of highest prevalence. Lancet 2008;371:1305–7.
6. World Health Organization. WHO Guideline: Updates on the man-
agement of severe acute malnutrition in infants and children. Geneva
(Switzerland): World Health Organization; 2013.
7. Opintan JA, Newman MJ, Ayeh-Kumi PF, Affrim R, Gepi-Attee R,
Sevilleja JEAD, Roche JK, Nataro JP, Warren CA, Guerrant RL. Pe-
diatric diarrhea in southern Ghana: etiology and association with in-
testinal inflammation and malnutrition. Am J Trop Med Hyg 2010;83:
936–43.
8. Campbell DI, Murch SH, Elia M, Sullivan PB, Sanyang MS, Jobarteh
B, Lunn PG. Chronic T cell-mediated enteropathy in rural west African
children: relationship with nutritional status and small bowel function.
Pediatr Res 2003;54:306–11.
9. Sullivan PB. Studies of the small intestine in persistent diarrhea and
malnutrition: the Gambian experience. J Pediatr Gastroenterol Nutr
2002;34(Suppl 1):S11–3.
10. Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel
disease: clinical aspects and treatments. J Inflamm Res 2014;7:113–20.
11. Vinolo MAR, Rodrigues HG, Nachbar RT, Curi R. Regulation of in-
flammation by short chain fatty acids. Nutrients 2011;3:858–76.
12. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud D-J,
Bakker BM. The role of short-chain fatty acids in the interplay between
diet, gut microbiota, and host energy metabolism. J Lipid Res 2013;54:
2325–40.
13. Macia L, Tan J, Vieira AT, Leach K, Stanley D, Luong S, Maruya M,
Ian McKenzie C, Hijikata A, Wong C, et al. Metabolite-sensing re-
ceptors GPR43 and GPR109A facilitate dietary fibre-induced gut ho-
meostasis through regulation of the inflammasome. Nat Commun 2015;
6:6734.
14. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P,
Liu H, Cross JR, Pfeffer K, Coffer PJ, et al. Metabolites produced by
commensal bacteria promote peripheral regulatory T-cell generation.
Nature 2013;504:451–5.
15. Rytter MJH, Kolte L, Briend AA, Friis H, Christensen VB. The im-
mune system in children with malnutrition:–a systematic review. PLoS
One 2014;9:e105017.
16. Jones KDJ, Berkley JA. Severe acute malnutrition and infection.
Paediatr Int Child Health 2014;34(Suppl 1):S1–29.
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